Hot Features
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company’s lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac diseas... Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company’s lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes. Forte Biosciences, Inc. is headquartered in Dallas, Texas. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.71 | -8.90161374284 | 19.21 | 19.45 | 15.51 | 323984 | 16.8890249 | CS |
| 4 | -8.92 | -33.7623012869 | 26.42 | 27.02 | 15.51 | 247291 | 19.75088026 | CS |
| 12 | -9.8 | -35.8974358974 | 27.3 | 35.7999 | 15.51 | 303320 | 26.91843951 | CS |
| 26 | -1.99 | -10.2103642894 | 19.49 | 35.7999 | 15.51 | 253130 | 27.81127572 | CS |
| 52 | 5.98 | 51.9097222222 | 11.52 | 35.7999 | 9.1 | 175943 | 23.57509032 | CS |
| 156 | 16.5055 | 1659.67823027 | 0.9945 | 35.7999 | 0.2796 | 131655 | 15.99340827 | CS |
| 260 | -24.72 | -58.5504500237 | 42.22 | 42.69 | 0.2796 | 253602 | 9.31740261 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.